3-substituted-1,4-diazepan-2-one melanocortin-5 receptor antagonists

Details for Australian Patent Application No. 2009219108 (hide)

Owner Mimetica Pty Ltd

Inventors Cassidy, Peter Joseph; Blaskovich, Mark Arnold Thomas

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2009219108

PCT Pub. Number WO2009/105825

Priority 61/032,898 29.02.08 US

Filing date 27 February 2009

Wipo publication date 3 September 2009

International Classifications

C07D 243/08 (2006.01) Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms

A61K 31/551 (2006.01) - having two nitrogens as ring hetero atoms, e.g. clozapine, dilazep

A61P 17/08 (2006.01) Drugs for dermatological disorders

A61P 17/10 (2006.01) Drugs for dermatological disorders

C07D 401/06 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 403/06 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

Event Publications

2 September 2010 PCT application entered the National Phase

  PCT publication WO2009/105825 Priority application(s): WO2009/105825

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009219109-A height safety system

2009219107-Methods of modulating the activity of the MC5 receptor and treatment of conditions related to this receptor